News Industry News Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure October 27, 2015
News Industry News Medical Therapy With Ranolazine Did Not Reduce Adverse Events In Patients With Persistent Untreated Heart Artery Blockages After Percutaneous Coronary Intervention October 13, 2015
News Industry News Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union September 28, 2015
News Conference News ESC 2015 Ezetimibe Benefits Diabetics, and Does Not Increase Risk of New-Onset Diabetes Yael L. Maxwell September 01, 2015
News Conference News ESC 2015 TECOS: No Differences in Heart Failure Outcomes When Sitagliptin Added to Usual Care in Diabetics Yael L. Maxwell August 31, 2015
News Conference News ESC 2015 Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients L.A. McKeown August 31, 2015
News Daily News Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients August 06, 2015
News Daily News Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib August 04, 2015
News Daily News BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries Yael L. Maxwell July 29, 2015
News Daily News ICDs Often Not Given to Older Patients After Acute MI, Outcomes Suffer Todd Neale June 25, 2015